Mini‐review: Update on the genetics of schizophrenia

@article{Coelewij2018MinireviewUO,
  title={Mini‐review: Update on the genetics of schizophrenia},
  author={Leda Coelewij and David Curtis},
  journal={Annals of Human Genetics},
  year={2018},
  volume={82},
  pages={239 - 243}
}
A number of important findings have recently emerged relevant to identifying genetic risk factors for schizophrenia. Findings using common variants point towards gene sets of interest and also demonstrate an overlap with other psychiatric and nonpsychiatric disorders. Imputation of variants of the gene for complement component 4 (C4) from GWAS data has shown that the predicted expression of the C4A product is associated with schizophrenia risk. Very rare variants disrupting SETD1A, RBM12 or… 
Assessment of Potential Clinical Role for Exome Sequencing in Schizophrenia.
TLDR
The diagnostic yield from exome sequencing in schizophrenia is low and disruptive and damaging variants seen in known neuropsychiatric genes should not be automatically assumed to have an etiological role if observed in a patient with schizophrenia.
In-silico investigation of coding variants potentially affecting the functioning of the glutamatergic N-methyl-D-aspartate receptor in schizophrenia
TLDR
The results are consistent with the hypothesis that ∼0.5% of patients with schizophrenia have disruptive or damaging genetic variants, which could plausibly impair functioning of NMDAR directly or indirectly through impairing Fyn function.
Rare copy number variants in individuals at clinical high risk for psychosis: Enrichment of synaptic/brain‐related functional pathways
  • V. Jagannath, E. Grünblatt, S. Walitza
  • Psychology, Medicine
    American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics
  • 2019
TLDR
Investigating the role of rare genome‐wide CNVs in clinical high risk for psychosis (CHR‐P) individuals suggested that rare CNVs might affect synaptic/brain‐related functional pathways in CHR‐P individuals.
[Genotype - phenotype relationships in view of recent advances in the understanding of genetic causes of schizophrenia].
TLDR
The concept of phenotype as applied to schizophrenia is the product of the combined effect of environmental factors and epigenetic changes that affect gene expression, taking into account tissue specificity and the degree of cell stimulation.
Genetic Risk Assessment in Psychiatry.
  • H. Peay
  • Psychology, Medicine
    Cold Spring Harbor perspectives in medicine
  • 2019
TLDR
Research on the genetic and environmental factors that increase risk for schizophrenia and etiologically related disorders are reviewed, guidance in determining and communicating risks to families is delivered, and new opportunities and challenges that will come with translating new research findings to psychiatric risk assessment and genetic counseling are anticipated.
Cross-platform validation of neurotransmitter release impairments in schizophrenia patient-derived NRXN1-mutant neurons
TLDR
Heterozygous NRXN1 deletions robustly impair synaptic function in human neurons regardless of genetic background, enabling future drug discovery efforts.
FXR1 regulation of parvalbumin interneurons in the prefrontal cortex is critical for schizophrenia-like behaviors
TLDR
The function of a newly identified SCZ risk gene in SCZ-relevant neurons is unveiled and a therapeutic target and a potential noninvasive treatment for psychiatric disorders are identified.
Contribution of de novo and inherited rare CNVs to very preterm birth
TLDR
The findings suggest that the rate of de novo CNVs, especially rare pathogenicCNVs, could be elevated in those born very preterm, however, a much larger study will need to be conducted to corroborate this conclusion.
Two Thalamic Regions Screened Using Laser Capture Microdissection with Whole Human Genome Microarray in Schizophrenia Postmortem Samples
TLDR
Using two regions in the same subject to identify disease-relevant gene expression differences was novel and reduced intersubject heterogeneity of findings, and manual curation of the data may support transcription repression.
...
...

References

SHOWING 1-10 OF 34 REFERENCES
Recent genetic findings in schizophrenia and their therapeutic relevance
TLDR
This review summarises recent schizophrenia genetic findings and some key issues they raise, particularly with regard to their implications for identifying and validating novel drug targets.
A polygenic burden of rare disruptive mutations in schizophrenia
TLDR
Analysis of exome sequences of schizophrenia cases and controls shows a polygenic burden primarily arising from rare, disruptive mutations distributed across many genes, suggesting that population-based exome sequencing can discover risk alleles and complements established gene-mapping paradigms in neuropsychiatric disease.
Mutation intolerant genes and targets of FMRP are enriched for nonsynonymous alleles in schizophrenia
  • G. Leonenko, A. Richards, M. O’Donovan
  • Psychology, Medicine
    American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics
  • 2017
TLDR
The genetic architecture of schizophrenia is delineated by excluding a role for uncommon exomic variants that confer a relatively large effect (odds ratio [OR] > 4) and it is shown risk alleles within this frequency range exist, but confer smaller effects and should be identified by larger studies.
The contribution of rare variants to risk of schizophrenia in individuals with and without intellectual disability
TLDR
It is shown that rare, damaging variants contribute to the risk of schizophrenia both with and without intellectual disability and support an overlap of genetic risk between schizophrenia and other neurodevelopmental disorders.
Biological Insights From 108 Schizophrenia-Associated Genetic Loci
TLDR
Associations at DRD2 and several genes involved in glutamatergic neurotransmission highlight molecules of known and potential therapeutic relevance to schizophrenia, and are consistent with leading pathophysiological hypotheses.
De novo mutations in schizophrenia implicate synaptic networks
TLDR
Genes affected by mutations in schizophrenia overlap those mutated in autism and intellectual disability, as do mutation-enriched synaptic pathways, and pathophysiology shared with other neurodevelopmental disorders.
Schizophrenia risk from complex variation of complement component 4
TLDR
It is found that many structurally diverse alleles of the complement component 4 (C4) genes generated widely varying levels of C4A and C4B expression in the brain, with each common C4 allele associating with schizophrenia in proportion to its tendency to generate greater expression of C 4A.
Rare loss-of-function variants in SETD1A are associated with schizophrenia and developmental disorders
TLDR
It is suggested that epigenetic dysregulation, specifically in the histone H3K4 methylation pathway, is an important mechanism in the pathogenesis of schizophrenia.
Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects
TLDR
A centralized analysis pipeline was applied to a SCZ cohort of 21,094 cases and 20,227 controls and Suggestive support was found for eight additional candidate susceptibility and protective loci, which consisted predominantly of CNVs mediated by nonallelic homologous recombination.
...
...